This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of various drugs, including those targeting neurological and psychiatric disorders. Its structure is often incorporated into molecules designed to interact with neurotransmitter systems, such as serotonin and dopamine, making it valuable for creating potential antidepressants, anxiolytics, or antipsychotics. Additionally, it is employed in the study of receptor binding and drug metabolism, aiding in the optimization of therapeutic agents. Its hydrobromide salt form enhances stability and solubility, facilitating its use in laboratory and industrial settings.